ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Artificial Intelligence
      • Beyond Basic Beta
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Education
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Managed Futures
      • Market Insights
      • Modern Alpha
      • Responsible Investing
      • Retirement Income
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Commodities
        • Gold/Silver/Critical Minerals
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook Channel
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. If Hillary Clinton Wins
  2. The Effect on Healthcare ETFs If Hillary Wins
If Hillary Clinton Wins
Share

The Effect on Healthcare ETFs If Hillary Wins

Aaron LevittSep 26, 2016
2016-09-26

Giving our growing and aging population, investing in the healthcare sector remains a popular portfolio position for many people. Rising demand and costs have played directly in the profits – and share prices – of the stocks operating in the sector. However, despite the bullish trends of the sector, healthcare hasn’t gone without a few hiccups.

And one of the biggest could be this upcoming Presidential election cycle.

Hillary Clinton and rival Donald Trump are completely different when it comes to healthcare policies, with Hillary making healthcare a main campaign platform. Given her strong stance, the sectors various healthcare exchange-traded funds (ETFs) will all be affected – and some in a few less-than-bullish ways.

Don’t Forget HillaryCare

While President Obama gets much of the credit for launching the United States’ healthcare reform bill, known as the Patient Protection and Affordable Care Act (ACA), Clinton should also get a nod. Before there was Obamacare, there was HillaryCare.

During her husband Bill Clinton’s presidency, Hillary fought hard and helped drafted the Health Security Act. That bill was a major stepping stone towards providing universal healthcare for all Americans. Even though the bill was killed, several of the act’s provisions ended up making their way into the ACA/Obamacare.

Since that time, Hillary has continued to push for major healthcare reforms and her campaign policies reflect that. Aside from vowing to keep the ACA in force, Hillary has looked to expand coverage under the bill. That includes allowing any state offering a Medicaid expansion to receive a 100% match from the federal government.

Hillary has also taken a hard stance on rising prescription drug prices. According to a new report by federal health agencies, prescription drug spending rose 12.6% back in 2014. The Fed’s anticipate that drug costs will rise 7.3% a year, through 2018. That rate is substantially higher than rates of inflation, and puts many Americans at risk of not being able to afford their medication. Clinton has already vowed probes into many drug makers’ pricing practices. Also on the pricing front, Hillary has embraced various generics and biosimilar drugs.

Finally, Clinton’s policies include a healthy dose of helping the poor and expanding on other often-ignored health services. Expanded coverage for primary care of America’s poorest citizens, as well as supporting mental health and women’s healthcare, are all on her docket.


Content continues below advertisement

The Healthcare ETF Plays

The crux of her healthcare plan involves making sure the ACA stays in place and isn’t vetoed/removed by rival lawmakers. If Hillary is successful, the continued rise in the number of insured citizens will undoubtedly benefit insurance stocks. We’ve already seen that effect since the ACA’s inspection.

TickerNameIssuerETFdb CategoryExpense Ratio
(IHF A-)iShares U.S. Healthcare Providers ETFiSharesHealthcare & Biotech Equities0.44%
(XBI A)SPDR S&P Biotech ETFState StreetHealthcare & Biotech Equities0.35%
(LABD B)Direxion Daily S&P Biotech Bear 3x SharesDirexionInverse Equities0.95%
(GNRX )VanEck Vectors Generic Drugs ETFVanEck GlobalHealthcare & Biotech Equities0.65%
(VHT A+)Vanguard Healthcare ETFVanguardHealthcare & Biotech Equities0.12%

This will benefit the $600 million iShares U.S. Healthcare Providers ETF (IHF A-). IHF tracks the Dow Jones U.S. Select Healthcare Providers Index – basically the ‘who’s who’ of healthcare insurance stocks, as well as hospital administrators, laboratory outsourcing firms and other health services firms. While insurance companies like to complain about Obamacare losses on the private side, the bulk of their revenues actually come from Medicare/Medicaid. Both those roles have been expanded in the wake of the ACA. IHF charges just 0.44% in expenses.

However, for healthcare investors, Clinton’s policies on drug prices could spell trouble for the SPDR S&P Biotech ETF (XBI A). Rising biotech drug costs are one of the reasons why prescription drug expenses for many Americans have gone up, and more recently, several biotech firms have come under pressure for their pricing practices. XBI tracks a basket of the largest biotech stocks and equal weights them. This means the ‘problem children’ could affect the index as much as the good eggs. That could make the ETF a strong sell if Clinton is elected and her policies are enacted. Investors looking to take that one-step further and bet on a biotech decline could use the leveraged inverse Direxion Daily S&P Biotech Bear 3x Shares (LABD B). The ETF effectively shorts the XBI with some leverage.

If biotechs are going to lose, then generic drug manufacturers could soar under a Clinton Presidency, as they get more business from Medicare/Medicaid and other health plans. The VanEck Vectors Generic Drugs ETF (GNRX ) hones in on that opportunity. It follows 79 of the largest global firms dedicated to the manufacturer of generics and biosimilars. While the fund has struggled to gain assets, a Clinton win could propel the ETF forward and gain enough recognition to make it a valid product.

The Bottom Line

When it comes to healthcare policy, Hillary Clinton kind of wrote the book on today’s modern reforms in America. Her policies will go towards strengthening the ACA and expanding its coverage. This means aggressive pricing policies will help to keep the lid on rising drug costs. Under that scenario, there will be a split between the winners and the losers of the healthcare sector, which will be reflected in the stocks and ETFs that track healthcare. In the end, a broad ETF like the Vanguard Healthcare ETF (VHT A+) could be an investor’s best bet under Clinton.

» Popular Pages

  • Tickers
  • Articles

Dec 06

Increased Correlations an Ongoing Threat to Traditional Portfolios

Dec 06

EU ETS Could Rally on Improving Macroeconomic Factors

Dec 06

READ: ETF of the Week: Know What's Under The Hood

Dec 06

Move Confidently Into 2024 With NEOS ETFs

Dec 06

4 Active REIT ETFs for 2024

Dec 06

CIO Thoughts: Don't Wait Too Long

Dec 06

Polycrisis: From Diagnosis to Action

Dec 06

The S&P 500, Dow and Nasdaq Since Their 2000 Highs - December

Dec 06

Active Small-Cap ETF TMSL Sees Strong Returns

Dec 06

Bull vs. Bear: ESG ETFs, the Post-Hype Sleeper?

QQQ

Invesco QQQ Trust Series I

SPY

SPDR S&P 500 ETF Trust

VOO

Vanguard S&P 500 ETF

IVV

iShares Core S&P 500 ETF

VGT

Vanguard Information...

SCHD

Schwab US Dividend Equity ETF...

GLD

SPDR Gold Shares

XLK

Technology Select Sector SPDR...

SMH

VanEck Semiconductor ETF

VUG

Vanguard Growth ETF

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X